Cargando…

Balancing Between Ischemic and Bleeding Risk in PCI Patients With ‘Bi-Risk’

Detalles Bibliográficos
Autor principal:	Park, Mahn-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989789/ https://www.ncbi.nlm.nih.gov/pubmed/35388999 http://dx.doi.org/10.4070/kcj.2021.0429

Ejemplares similares

Triple therapy after PCI – Warfarin treatment quality and bleeding risk
por: Wadell, Daniel, et al.
Publicado: (2018)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI Patients
por: Wang, Hao-Yu, et al.
Publicado: (2022)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
por: Dobies, David R, et al.
Publicado: (2015)

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023)

PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017)

Thrombosis and Major Bleeding Risk After Primary PCI Among Patients With Multivessel Coronary Artery Disease
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Need for Elective PCI Prior to Noncardiac Surgery: High Risk Through the Eyes of the Beholder
por: Garcia, Santiago, et al.
Publicado: (2014)

Bronchoscopy and bleeding risk
por: Herth, Felix J.F.
Publicado: (2017)

Redefining successful primary PCI
por: McCartney, Peter J, et al.
Publicado: (2019)

Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI
por: Wang, Hao-Yu, et al.
Publicado: (2022)

Evidence based decision making between PCI and CABG
por: Collet, Carlos
Publicado: (2019)

Public reporting of PCI operator outcomes
por: Kelham, Matthew D., et al.
Publicado: (2019)

Before Coronary CTO PCI: Burden or Location?
por: Choi, Woong Gil
Publicado: (2022)

How to Manage a Patient with Haemophilia and ACS Requiring PCI: A Battle between Bleeding and Thrombosis
por: Theodoropoulos, Konstantinos C., et al.
Publicado: (2021)

Managing Coronary Thrombus in the Cath Lab During PCI
por: Ambrose, John A
Publicado: (2012)

Left Main PCI, Still a Main Issue
por: Shakerian, Farshad
Publicado: (2013)

Balancing risk and benefit during coronavirus
por: Sehn, Laurie H.
Publicado: (2020)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
por: Edmiston, Marissa K., et al.
Publicado: (2018)

Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?
por: Heo, Nae-Yun
Publicado: (2020)

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019)

Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI
por: Wang, Hao-Yu, et al.
Publicado: (2020)

Is FAME 2 a breakthrough for PCI in stable coronary disease?
por: Sechtem, Udo
Publicado: (2014)

The Need for Re-evaluation of PCI Practice: from Proceduralists to Clinicians
por: Kim, Min Chul, et al.
Publicado: (2019)

Management of Antithrombotics before Endoscopy-Balancing the Risks
por: Kim, Joon Sung, et al.
Publicado: (2022)

Predicting the Bleeding Risk for Patients on Anticoagulant Therapy Prior to Gastric Endoscopic Submucosal Dissection
por: Kim, Jie-Hyun
Publicado: (2022)

US Growth in PCI Care—Less than Ideal, but is the Ideal Less?
por: Bradley, Steven M., et al.
Publicado: (2013)

What is the ideal fibrinolysis to PCI time: Pharmaco-invasive strategy with streptokinase?
por: Mishra, Sundeep
Publicado: (2017)

Seeking a better risk-prediction model for upper gastrointestinal bleeding
por: Lim, Sun Gyo
Publicado: (2022)

Benefit-risk balance of COVID drugs. New prospects
por: Cracowski, Jean-Luc, et al.
Publicado: (2022)

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit
por: Ewer, Michael S, et al.
Publicado: (2016)

Balancing risks and benefits of artificial intelligence in the health sector
por: Goodman, Kenneth, et al.
Publicado: (2020)

Neurosurgical innovation: balancing the risks and benefits of technical novelty
por: Cohen-Gadol, Aaron A.
Publicado: (2019)

The Single‐access for Hi‐risk PCI (SHiP) technique
por: Wollmuth, Jason, et al.
Publicado: (2019)

The Second Report from K-PCI Registry: a Step toward Continuous Systemic Monitoring of Korean Percutaneous Coronary Intervention Practice
por: Won, Hoyoun, et al.
Publicado: (2019)

Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis
por: Mankerious, Nader, et al.
Publicado: (2023)

Ultra-low CONtraSt PCI vs conVEntional PCI in patients of ACS with increased risk of CI-AKI (CONSaVE-AKI)()()
por: Shrivastava, Abhinav, et al.
Publicado: (2022)

Risk score to predict gastrointestinal bleeding after acute ischemic stroke
por: Ji, Ruijun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gl92m4fssautfb26nv0pt7e2l8